Siga Technologies (SIGA) Cash from Investing Activities Growth (1y) (2011 - 2025)
Siga Technologies (SIGA) Cash from Investing Activities Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | -308.05% |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | -41.51% |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | -139.86% |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | 129.18% |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | 1.71% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | -366.90% |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | -96.43% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Siga Technologies | 212.67 Mn | 57.70 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1,191.19% |
| Jun 30, 2025 | 99.95% |
| Jun 30, 2024 | 89.92% |
| Mar 31, 2021 | 11.46% |
| Mar 31, 2020 | -73.18% |
| Dec 31, 2019 | -100.00% |
| Jun 30, 2019 | 100.01% |
| Dec 31, 2018 | 170,677.62% |
| Jun 30, 2018 | 29.15% |
| Dec 31, 2017 | -103.82% |
| Sep 30, 2017 | -1,491,700.00% |
| Jun 30, 2017 | -1,458.70% |
| Dec 31, 2016 | 2,720.09% |
| Sep 30, 2016 | 100.00% |
| Mar 31, 2016 | -100.21% |
| Dec 31, 2015 | -2,027.65% |
| Sep 30, 2015 | 98.41% |
| Mar 31, 2015 | 28,300.79% |
| Dec 31, 2014 | 99.26% |
| Sep 30, 2014 | -1,794.05% |